Trouble At Europharma: Danish Regulators Call For New CEO
Executive Summary
Europharma is seeking a new CEO after being stripped of its GMP (good manufacturing practice) certification by Denmark's medicines regulator on the back of whistleblower complaints and investigations at the company's manufacturing site. Danish regulators are demanding new senior management be appointed before they will lift the ban.